Investigation of Repeatability of Peak Nasal Inspiratory Flow Rate Measurements Under Baseline Conditions and After Administration of 0.05% Oxymetazoline
- 6 May 2021
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 36 (1) , 41-46
Abstract
Objectives: Peak nasal inspiratory flow (PNIF) measurement is an inexpensive and user-friendly method to assess nasal patency. However, the repeatability of PNIF measurements, as well as the threshold value of a change in PNIF, which can be considered significant remain unclear. This study aims to investigate the repeatability of PNIF measurements and the change in PNIF after the administration of 0.05% oxymetazoline. Methods: Repeated measurements of PNIF (Clement Clarke In-Check nasal inspiratory flow meter; Clement Clarke International, Ltd, Harlow, Essex, UK) were obtained in 333 healthy volunteers (174 women). Based on age, participants were categorized into three groups (6–7 years, 13–14 years, and 20–45 years). We obtained five measurements in each participant. PNIF was remeasured in 294 subjects 30 min after administration of 0.05% oxymetazoline. The variability in PNIF measurements was assessed using the coefficient of variation (CV = standard deviation × 100%/mean). Results: The first four PNIF measurements significantly differed from each other. The difference in PNIF measurements ceased to be statistically significant only between the fourth and fifth measurements (p = 0.19). PNIF repeatability was acceptable; the median CV was 15.5% (0–66), which did not significantly differ between age groups. The administration of 0.05% oxymetazoline led to a statistically significant increase in the PNIF value by 14.3% (−45, 157%) (p = 0.000000). Conclusions: 1. No statistically significant difference was observed in PNIF values only between the fourth and fifth measurements; therefore, at least three measurements are essential to draw meaningful conclusions. 2. PNIF measurements were satisfactorily characterized by a relatively low CV (15%). 3. The administration of 0.05% oxymetazoline led to an increase in PNIF by approximately 14% over the baseline value.Keywords
This publication has 19 references indexed in Scilit:
- Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practiceAllergy, 2015
- Correlation between peak nasal inspiratory flow and peak expiratory flow in children and adolescentsRhinology journal, 2012
- Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomesJournal of Immunological Methods, 2012
- Nasal steroids improve regulation of nasal patency in asthma and mild rhinitis: a randomised, cross-over trial2011
- Reference values for peak nasal inspiratory flow in children and adolescents in BrazilRhinology journal, 2011
- Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2011
- Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitisClinical & Experimental Allergy, 2009
- Quality‐of‐life and asthma‐severity in general population asthmatics: results of the ECRHS II studyAllergy, 2008
- Interpretative strategies for lung function testsEuropean Respiratory Journal, 2005
- Repeatability of peak nasal inspiratory flow measurements and utility for assessing the severity of rhinitisAllergy, 2005